Life Sciences AISeedWorkflowℹ114 viewsProxima Bio
Proxima Bio, formerly VantAI, is an AI-native platform for proximity-based drug discovery, mapping protein-protein interactions to design medicines that reshape protein networks rather than inhibit single targets.
Startup snapshot
- Stage
- Seed
- Funding
- Seed · $80M · January 2026
- Status
- published
- Updated
- Jun 21, 2026
- Views
- 114 views
- Category
- Life Sciences AI
- Website
- proximabio.com
What they're building
Proxima Bio, formerly VantAI, is an AI-native platform for proximity-based drug discovery, mapping protein-protein interactions to design medicines that reshape protein networks rather than inhibit single targets.
Founders
Zachary Carpenter
Co-founder & CEO
Luca Naef
Co-founder & CTO
Foundation model usage
- Architecture pattern
- Agentic loops, Multimodal processing
- Model demand
- High intensity
Funding
Latest funding: Seed · $80M · January 2026. Total raised: $80M. Lead investor: DCVC.
AI Lab Fit
Strong fit for multimodal reasoning, biological data retrieval, molecule and protein analysis, structured extraction, and research copilots.
Notes
Proxima Bio is tagged workflow based on buyer clarity, repeat workflow activity, public activity, and fit with the AI Atlas map.
Related NYC startups
Output Biosciences is building Large Biological Models, generative AI architectures designed to handle the long, nonlinear, fragmented data of biological systems across molecules, cells, and organisms.
Output Biosciences is building Large Biological Models, generative AI architectures designed to handle the long, nonlinear, fragmented data of biological systems across molecules, cells, and organisms.
Life Sciences AIWorkflowℹ49viewsRecent Activity
Serinus Biosciences uses a knowledge-primed AI engine to design cancer combination therapies by mapping how tumor cells evolve treatment resistance and identifying molecules that override resistance escape routes.
Serinus Biosciences uses a knowledge-primed AI engine to design cancer combination therapies by mapping how tumor cells evolve treatment resistance and identifying molecules that override resistance escape routes.
Life Sciences AIWorkflowℹ138viewsRecent Activity